Skip to content

Study · Not a test of the peptide alone · 2018

1 result

[The use of immunomodulators, antioxidants and hepatoprotectors for the correction of the liver, erythrocites and the immune system disorders in chronic ethanol intoxication].

Dolgareva SA, Sorokin AV, Konoplya NA, Bushmina ON, Bystrova NA, Ovod AI

Biomeditsinskaia khimiia1 Aug 2018

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Gepon was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Gepon.

  1. 01AnimalNot a test of Gepon aloneAnimal study (in vivo)Efficacy outcome

    In experimental chronic ethanol intoxication, Hepon with Hypoxen and Phosphogliv corrected immune-metabolic disorders less effectively than the two other combinations.

    In plain wordsIn experimental chronic ethanol intoxication, Hepon with Hypoxen and Phosphogliv corrected immune-metabolic disorders less effectively than the two other combinations.

    Peptide
    Gepon
    Outcome
    DecreaseCorrection of immune-metabolic disorders
    Study

    n: not reported in source

    Chronic ethanol intoxication
    Comparator
    Longidasa, Mexicor and Essentiale forte N, or Glutoxim, Mexidol and Heptral
    Outcome group
    Immune response · Whole body

    Source sentences

    Summary
    Combined use of "Longidasa", "Mexicor", "Essentiale forte N" or "Glutoxim", "Mexidol", "Heptral" was more effective in the correction of immune-metabolic disorders in chronic alcohol intoxication than "Hepon", "Hypoxen" and "Phosphogliv".
    1 context sentence
    Summary · context
    The effectiveness of three various combinations of an immunomodulator with an antioxidant and a membrane protector in the correction of metabolic and immune disorders has been studied in the experiment under 60-days ethanol intoxication.

    In this study, Gepon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Gepon.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.